Waverley Pharma Inc. (TSXV:WAVE)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Apr 10, 2026, 9:30 AM EST
Waverley Pharma Market Cap
Waverley Pharma has a market cap or net worth of CAD 540 thousand as of April 13, 2026. Its market cap has decreased by -87.50% in one year.
Market Cap
540.00K
Enterprise Value
3.70M
Revenue
1.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 27, 2017, Waverley Pharma's market cap has decreased from 27.00M to 540.00K, a decrease of -98.00%. That is a compound annual growth rate of -37.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 540.00K | -50.00% |
| Dec 22, 2025 | 1.08M | 100.00% |
| Dec 31, 2024 | 540.00K | -60.00% |
| Dec 22, 2023 | 1.35M | -16.67% |
| Dec 28, 2022 | 1.62M | -62.50% |
| Dec 30, 2021 | 4.32M | -36.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Algernon Health | 2.71M |
| Appili Therapeutics | 2.65M |
| BioVaxys Technology | 2.65M |
| Rakovina Therapeutics | 2.11M |
| Universal Ibogaine | 1.56M |
| Entheon Biomedical | 1.39M |
| Vaxil Bio | 597.60K |
| ChitogenX | 415.65K |